EVANIUM, a nutraceutical startup based in Regensburg, Germany, has raised €2.2 million in seed funding from FoodLabs, Feast Ventures, and several business angels.
The company develops OPTISOLV, a dual-coating technology designed to improve the solubility, stability, and bioavailability of plant-based active ingredients used in supplements, functional food, and nutricosmetics.
According to the company, the new capital will be used to expand its product portfolio, advance clinical studies and validation, scale the technology platform, build new industry partnerships, and support international market expansion.
The round highlights continued investor interest in technologies aimed at addressing one of the nutraceutical sector's persistent challenges: improving how effectively active ingredients are absorbed by the body.
The company develops OPTISOLV, a dual-coating technology designed to improve the solubility, stability, and bioavailability of plant-based active ingredients used in supplements, functional food, and nutricosmetics.
According to the company, the new capital will be used to expand its product portfolio, advance clinical studies and validation, scale the technology platform, build new industry partnerships, and support international market expansion.
The round highlights continued investor interest in technologies aimed at addressing one of the nutraceutical sector's persistent challenges: improving how effectively active ingredients are absorbed by the body.